|
|
Application of Octreotide and Pantoprazole combined with Raw Rhubarb in patients with acute pancreatitis |
XU Wei-xi XU Xi-lin YAO Qiu-ping |
Department of Gastroenterology,People′s Hospital in Wannian County of Shangrao City,Jiangxi Province,Wannian 335500,China |
|
|
Abstract Objective To explore the application of Octreotide and Pantoprazole combined with Raw Rhubarb in patients with acute pancreatitis.Methods A total of 60 patients with acute pancreatitis treated in our hospital from January 2017 to January 2019 were selected as research subjects.They were divided into a control group (n=30)and observation group (n=30)by themethod of touching a ball at random.Patients in the control group were treated with Octreotide in combination with oral administration of Raw Rhubarb.In the observation group,participants were treated with Octreotide in combination with Pantoprazole and oral administration of Raw Rhubarb.The changes of abdominal distension disappearance time,abdominal pain disappearance time,bowel sounds recovery time,time for blood glucose to return to normal,healthy life scores and inflammatory factor levels in the two groupswere compared.Results In the observation group,the abdominal distension disappearance time,abdominal pain disappearance time,bowel sounds recovery time,time for blood glucose to return to normalwere shorter than those of the control group,and the differences were statistically significant(P<0.05).The healthy life scores of the observation group after 3,6,12days after treatment were lower than those of the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of tumor necrosis factor-α(TNF-α)and interleukin-6(IL-6)in the observation group were lower than those of the control group,the differences were statistically significant(P<0.05).Conclusion Treating patients with acute pancreatitis by taking Octreotide combined with Pantoprazole and oral administration of Raw Rhubarb can effectively shorten the time of symptom alleviation,improve the quality of healthy life and control tumor necrosis factor,which has a great value of clinical application.
|
|
|
|
|
[1] |
刘红霞.生大黄联合丹参酮ⅡA磺酸钠和奥曲肽治疗急性胰腺炎的临床效果分析[J].社区医学杂志,2016,14(10):44-46.
|
[2] |
王兴鹏,李兆申,袁耀宗,等.中国急性胰腺炎诊治指南(2013年,上海)[J].中华消化杂志,2013,29(4):656-660.
|
[3] |
张晓辉,陈海涛,张旭,等.泮托拉唑钠联合奥曲肽治疗小儿急性胰腺炎对血清IL-2和IL-6的影响[J].河北医药,2016,38(12):1833-1835.
|
[4] |
刘佩湘.奥曲肽联合乌司他丁治疗急性胰腺炎的疗效观察[J].临床研究,2016,24(12):60-62.
|
[5] |
刘志勇,张庭伟.浅谈急性胰腺炎的中医药治疗[J].中国中医药咨讯,2011,3(21):145.
|
[6] |
邓超,李景辉,吴平安.奥曲肽联合乌司他丁治疗急性重症胰腺炎的临床研究[J].中国临床药理学杂志,2016,32(18):1653-1656.
|
[7] |
宋奇峰,周建波,桑建忠,等.乌司他丁联合奥曲肽对急性胰腺炎的临床疗效及预后分析[J].中国生化药物杂志,2016,6(7):158-160.
|
[8] |
张谨,任敏.奥曲肽和七叶皂苷钠联合治疗轻度急性胰腺炎应用效果研究[J].检验医学与临床,2016,13(16):2278-2280.
|
[9] |
刘元山.奥曲肽联合泮托拉唑治疗急性上消化道出血的临床疗效[J].临床合理用药杂志,2017,15(9):55-56.
|
[10] |
徐震林.低分子肝素联合乌司他丁治疗急性胰腺炎的效果观察[J].西南国防医药,2017,27(12):1262-1265.
|
[11] |
孙波.奥曲肽+泮托拉唑治疗急性上消化道出血的效果评价[J].临床医药文献电子杂志,2017,15(62):47-48.
|
[12] |
牛懿,李胜昔.联合应用泮托拉唑与奥曲肽治疗急性上消化道出血临床疗效研究[J].实用药物与临床,2019,22(3):293-295.
|
[13] |
李松霏,李文波,董倩倩,等.生长抑素及其类似物在急性胰腺炎治疗中的研究进展[J].中华胰腺病杂志,2017,17(2):140-143.
|
[14] |
袁楚明,陈梦云,李奕琏,等.早期应用生大黄对重症急性胰腺炎的疗效[J].陕西医学杂志,2007,7(1):31-33.
|
[15] |
刘金材.奥曲肽联合生大黄治疗急性胰腺炎的临床效果[J].临床合理用药杂志,2016,9(36):66-67.
|
|
|
|